|
Post by dreamboatcruise on Dec 16, 2017 16:33:45 GMT -5
@sportsrancho ... the answer on Brazil doesn't surprise me as certain things are likely up to the partner to accomplish, as they were with SNY. His general positive spin is what I'd expect from a competent CEO. Did anyone ask him about things like RLS tease? I'm assuming he didn't say anything. I'm suspecting there may be nothing to say. So wait a second..you’re actually thinking RLS is not going to result in anything for us...huh..you’re usually so upbeat It was included in a list of what was labeled "Near Term Milestones and Key Events" a few months ago, but was merely listed as "Receptor Life Sciences" with no indication of what the milestone or event actually is. Granted the way the slide was labeled leaves wiggle room as to whether some were near term and others longer term "key events", but I think management was trying to convince investors that RLS was going to have some sort of an important accomplishment that would benefit MNKD in the near term. I'm just wondering if there is something actually coming soon. The vagueness of including RLS in a list of milestones and events without saying what the event is much less when it is anticipated to occur is why I term it a "tease". I have no reason to suspect that RLS will fail to deliver, but am a bit circumspect about the list that was presented.
|
|
|
Post by dreamboatcruise on Dec 15, 2017 20:52:34 GMT -5
I just wanted to take some time out to wish all of my fellow MNKD longs a Merry Christmas and Happy Hanukkah. Here's to looking to a festive 2018 for MNKD.
My wish is that our suffering will be over and Mike C and team can get Afrezza over the goal line. I also hope that DBC see's rainbows and unicorns and smiles. (lol)
Ya'll are great
Peace out
Da Slug Thanks for the wishes, I will certainly be enjoying holiday festivities with the family. Here I would even be content with seeing less unfounded personal attacks... I don't require nor expect smiles or politeness from many here, much less rainbows (lol) A little apprehension for what January may bring us regarding share price. It has not been kind to us in the past. Though by this time next year we should, fingers crossed, have formed whatever new trough bottom we are heading into and already be climbing the other side. Next year in Jerusalem.
|
|
|
Post by dreamboatcruise on Dec 15, 2017 20:39:02 GMT -5
@sportsrancho... the answer on Brazil doesn't surprise me as certain things are likely up to the partner to accomplish, as they were with SNY. His general positive spin is what I'd expect from a competent CEO. Did anyone ask him about things like RLS tease? I'm assuming he didn't say anything. I'm suspecting there may be nothing to say.
|
|
|
Post by dreamboatcruise on Dec 15, 2017 20:35:11 GMT -5
Really silly for MNKD to even be considering doing any acquisitions...Any money they have should be going into selling Afrezza , funding pediatric and trep t trials. Those shares should be used to generate funding and get partnerships. I still don't understand whether they really believe they can go at this alone in the long run. I think it all depends on what the acquisition is and whether the acquisition is value-creating to the Mannkind shareholders. Let's suppose Mannkind acquires One Drop for certain number of Mannkind shares. If One Drop is actually cash flow positive right now and is expected to grow its cash flow further in the future and if Mannkind paid a good price (from the perspective of the Mannkind shareholders), I would not object to such an acquisition. I think One Drop is going to struggle now that a very well funded competitor has jumped into the market... SNY and Google backed OnDuo. Merging two struggling companies needing funding to fight against giants doesn't make a lot of sense to me. If MNKD has actually succeeded in getting One Drop to train their "coaches" on Afrezza usage, that's great... no need to buy them.
|
|
|
Post by dreamboatcruise on Dec 15, 2017 20:26:17 GMT -5
That's still limited to Type 1 diabetics. The change is that Type 1s between 18 and 20 can now get insurance cover for CGMs which is good. The better insurers already cover that age range as well as pediatrics. Type 2 diabetics are still out of luck. Only Type 1, hmmmm. So what is the definition of a type 1? When I do the google I get answers like this "In general, people with diabetes either have a total lack of insulin (type 1 diabetes) or they have too little insulin or cannot use insulin effectively (type 2 diabetes)." Well we know from beta cell replacement almost all T1 still have some beta cell function so the word "total" is wrong. Or I get answers like this "Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin." So do 70% of T2s become Type 1's? My dad for example started on the orinase, then the diabinese then one shot then two before having the massive heart attack. Based on the above definition was he at the end a type 1? Would he have qualified for the CGM? One thing I know is he sure could have used one when they first put him on the orinase. He would have been able to see what a mess it was making and he could have gone on the insulin day 2 which may have stopped the progression and limited the coronary disease. I thought the clear distinction between Type 1 and Type 2 is that Type 1 is autoimmune. I would have assumed they diagnosed it with antibody tests. I have a hypothyroidism disease of the autoimmune type (Hashimoto's Syndrome). The differential diagnoses being an antibody test. Many people get non-autoimmune hypothyroidism as they get older, but the autoimmune version often strikes earlier as it did with me, similar to the situation with diabetes.
|
|
|
Post by dreamboatcruise on Dec 15, 2017 20:18:15 GMT -5
I like in section 6, how the use of CGMs has been changed to all adults over 18 who are not at goal. The year of CGMs has begun. I had a family member pass less than a year ago who probably would still be alive if he had access to a CGM to expose the substandard care in his assisted living facility. Hopefully this will actually mean people have access through insurance, Medicare and Medicaid.
|
|
|
Post by dreamboatcruise on Dec 15, 2017 20:02:39 GMT -5
The link is between my right ear and left ear. Quite a strong link! Don't misunderstand, I'm all for manipulation in the right direction! Though manipulation rarely holds. And often it comes with somewhat delusional claims and attacks on more reasonable voices. That said, I'm at least glad it was the company itself that got to take advantage of the manipulation to above $6 this time around rather than simply pump and dump traders.
|
|
|
Post by dreamboatcruise on Dec 15, 2017 19:57:34 GMT -5
Volume has really dried up, as of yesterday largest clearing firm had no stock to lend (and yes I saw the loan rate thread), with volatility at extreme quiet levels and end of year approaching, the crickets you hear, (paint drying you see, grass growing, etc.) could soon be running when the noise hits looking forward to '18 In reality there are shares available for borrowing because some of min were returned and are now sitting unlent. I guess the system is perfect about locating and harvesting shares for loan.
|
|
|
Post by dreamboatcruise on Dec 11, 2017 17:27:30 GMT -5
It is rather interesting that what you say above that I've bolded is basically summing up two things I have posted today. It seems we both believe that shorts will use the authorization as a way of bashing... and as I posted over on the thread about the index relisting, I believe that should have positive effect on share price due to need for ETFs to buy. I do get that you judge the same thing coming from me entirely differently because you are judging it from an emotional rather than objective perspective. BTW, you can block me and then you will not see any of my posts, and of course I would post less if people don't directly address comments to me as you often do. I respect your right to think of the extra shares as amazingly positive. I reserve the right to respectfully view it (the magnitude of shares) differently. For what it's worth I recently lodged my guess here that we'll stay above $3, so you seem to be a little more pessimistic than I on potential for short term share price movement. I'll avoid acting like you are doing something evil for stating that view. "evil"? give me a break. DBC you have expressed your opinion a couple dozen times. How much reiteration does the board need given you have made your perspective clear. It's getting old and for that reason I don't go back for a 10th helping of more of the same. Other than that I usually read your contrarian view. What I'd like to know is Where would You go on a Dream BoatCruise? GLTY Would love to do Mediterranean cruise sometime. Though Alaska has an appeal as well. To be fair, this is actually off topic and the thing I should be talking about on this thread is the share authorization vote. Perhaps the moderators will choose to lock this thread when the vote is concluded. Given that most people have likely already voted, it's relevance is certainly not what it was as a debating ground for the merits of the vote. With my comment about "evil" I was humorously pointing out that if I were the one predicting that the price might well drop to $2.50, I would have people accusing me of spreading FUD, likely with at least an implicit accusation that I am a liar... a short instead of a shareholder. promann ... I'll do something you claim I never do. I fully support your suggestion above. People should simply ignore and not read anyone whose comments they do not value. There is actually an option to "block" me and then you will not even see posts from me so that I wouldn't even be creating clutter for you. I certainly don't think less of anyone if they think my opinions lack value. I do feel the moderators, and others, may not like if this thread is taken over with the off topic exercise of attacking me, so I'll leave my response on the subject at this post.
|
|
|
Post by dreamboatcruise on Dec 11, 2017 16:14:32 GMT -5
What are we up to now? 50, 60, 70 posts from you railing on and on and on about how bad the increased share issuance will be? Will you ever stop? We get it already. To everyone else on the Board, this endless stream of FUD reeks of a strong desire to inhibit folks on this Board from believing in the stock. I say DON'T TAKE IT SERIOUSLY. Also, with the coming Vote we are going to see fierce, fake downward pressure on the PPS designed to free longs from their shares. DON'T FALL FOR IT. Today the PPS should be up with the news relative to the Biotech index. It's not. I wonder why?I won't be surprised to see Wall Street Crooks take it down to nearly $2.50 to scare the living hell out of people and steal their shares. The YES vote will be a GREAT thing for MNKD. Hold tight despite the continued FUD and manipulation that is going to be launched and heaped on MNKD longs. It is rather interesting that what you say above that I've bolded is basically summing up two things I have posted today. It seems we both believe that shorts will use the authorization as a way of bashing... and as I posted over on the thread about the index relisting, I believe that should have positive effect on share price due to need for ETFs to buy. I do get that you judge the same thing coming from me entirely differently because you are judging it from an emotional rather than objective perspective. BTW, you can block me and then you will not see any of my posts, and of course I would post less if people don't directly address comments to me as you often do. I respect your right to think of the extra shares as amazingly positive. I reserve the right to respectfully view it (the magnitude of shares) differently. For what it's worth I recently lodged my guess here that we'll stay above $3, so you seem to be a little more pessimistic than I on potential for short term share price movement. I'll avoid acting like you are doing something evil for stating that view.
|
|
|
Post by dreamboatcruise on Dec 11, 2017 15:08:04 GMT -5
Just got this by email. I haven't read anything yet, but thought all of you would like to know of it's existence. Hello and welcome to our weekly MannKind newsletter! CEO Michael Castagna of MannKind has been spearheading awareness of Afrezza and working on perfecting the delivery of insulin for type 1 and 2 diabetes. He discusses his personal struggles with the disease and explains how with today's technology, this new product by Afrezza makes it possible to regulate and monitor your insulin level. For years diabetics have had to administer insulin intravenously. As a diabetic can you imagine inhaling your fast acting insulin with an on the go compact inhaler? Click below for the full interview with Michael Castagna and Business Radio- Sirius XM. To stay updated please visit our website and follow us on social media for daily and weekly content: @mannkindcorp “The secret to my success is that most people look at technology and say let’s go out and find a use for this technology. I typically do the reverse. I look for an unmet need and then find the technology to make it work.” - Alfred E. Mann Please tell me that didn't actually make it into a newsletter sent out by MNKD.
|
|
|
Post by dreamboatcruise on Dec 11, 2017 15:02:30 GMT -5
This thread is for the celebrating of (WAY over) 500 script count! 474 was what Symphony reported. There is already a thread discussing the disparity of these numbers. What's IMS's new rx and refill split? I am surprised the muted reactions this number has received so far given that so many of us had been waiting for the 500 breakthrough. The muted response is likely because you are comparing an Apple to an Orange. Unless I'm missing something we don't have IMS data for prior periods so we really have no idea whether this represents a jump in scripts or merely an offset in the number from Symphony estimates that may have existed all along. We roughly know that Symphony $$ numbers multiplied by 0.65 translates to MNKD revenue. If IMS numbers are consistently higher than Symphony it would mean any revenue projection based on them would need higher discount factor. Actual revenue is what matters, not finding some source of data that crosses an arbitrary threshold.
|
|
|
Post by dreamboatcruise on Dec 11, 2017 14:39:56 GMT -5
December 11, 2017 - MNKD has met certain criteria and, effective next Monday, MNKD will be added to the NASDAQ Biotech Index. 54 companies are being added while 15 are being removed. This is positive exposure for MNKD and offers the latest confirmation that others in the market believe MNKD is heading in the right direction. I don't believe there is anything subjective about it. It only means that we've met certain requirements like share price. Don't think there is any assessment of "direction" that is involved. This should have a positive effect on share price due to the demand for shares for index linked ETFs.
|
|
|
Post by dreamboatcruise on Dec 11, 2017 14:34:41 GMT -5
It seems unlikely that the vote will fail (despite a minority of us voting against it), so I would assume there won't be much of a share price reaction at all. I think it is already baked in... i.e. part of what pushed us down to where we are. My thought is that once the number of authorized shares is increased by 140 million, and the realization sinks in that MNKD has reloaded its source of capital and its cash position is no longer so precarious, the stock price will gravitate back to the 6's. Whether this happens quickly or gradually may depend on script growth and other developments. Assuming that the reported IMS script count from last week of 649 is in the right ball park, Symphony's numbers should soon catch up and 6 may not be that long a wait. I've spent a career as a tech entrepreneur and lived through periods such as the dotcom crash. I myself have been in precarious positions financially and I've personally known people whose companies went bankrupt. In my experience NO ONE ever points to unissued authorized shares as something that indicates financial stability or is somehow the same as cash position. Perhaps there are lots of investors such as yourself that view this as great news and removing some source of uncertainty. For others, it seems to have increased the uncertainty due to the magnitude of potential dilution which while not guaranteed will happen is now hanging in the air.
|
|
|
Post by dreamboatcruise on Dec 11, 2017 14:20:58 GMT -5
The authorization up for vote really isn't a shelf registration, and it certainly isn't somehow magical money. There is no money pending that management has talked of. Investors must be found before money comes in. There is dispute over how many shares should be authorized, but authorizing shares should have been a no brainer (would have been if not for MNKD's history and the magnitude they went for). Most companies that have financial problems have shares authorized but just can't find buyers for the shares. You're certainly engaging in counting chickens before they've hatched if you think authorizing shares somehow assures funding will come in. By your view of the authorization, it's an exercise in futility? You seem certain, by your responses related to this authorization to all postings, that nothing is certain. You are preaching to the choir and stating the obvious. I'd like to see you post your thoughts on what you believe is going to happen with the authorization and then let's see who is right? Fair enough? I think the authorization will pass. As for what the shares might be used for, management said very little about that, so there is little I would have to have a "belief" about it. I could make up something positive in my mind and start believing it but that I'd say is really a "wish", or I could imagine something negative and that would be a "fear". Those would not be informed rational beliefs. Though I guess my one prediction is that shorts will be using the magnitude of the authorization to suggest that massive dilution is still in our future, and the overhang of such will depress the share price below where it otherwise would have been (though this part is somewhat untestable prediction since we don't have a way of comparing what does happen to what would have happened if they say had only authorized 40M shares). No it isn't an exercise in futility, but it certainly isn't in itself raising money. Think of it like ordering checks from the bank when you run out. It's necessary to have them to conduct your financial transactions (or at least back in the olden days it was necessary), but the checks themselves do not mean money appears in your bank account.
|
|